A Descriptive analysis of a Real-World Population with Chronic Hepatitis C (CHC) treated with Simeprevir (SMV)- and/or Sofosbuvir (SOF)-based regimens- findings from a us payer database
Abstract
Authors
J. Forlenza J. Fortier F. Laliberté P. Lefebvre N. Tandon